12-120768379-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_139015.5(SPPL3):c.719A>G(p.Asn240Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00012 in 1,614,164 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_139015.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SPPL3 | ENST00000353487.7 | c.719A>G | p.Asn240Ser | missense_variant | Exon 8 of 11 | 1 | NM_139015.5 | ENSP00000288680.4 | ||
SPPL3 | ENST00000545209.1 | n.253A>G | non_coding_transcript_exon_variant | Exon 1 of 4 | 1 | |||||
SPPL3 | ENST00000392495.7 | n.1295A>G | non_coding_transcript_exon_variant | Exon 2 of 5 | 2 | |||||
SPPL3 | ENST00000536996.5 | c.*59A>G | downstream_gene_variant | 5 | ENSP00000442484.1 |
Frequencies
GnomAD3 genomes AF: 0.000361 AC: 55AN: 152176Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000191 AC: 48AN: 251430Hom.: 0 AF XY: 0.000132 AC XY: 18AN XY: 135890
GnomAD4 exome AF: 0.0000944 AC: 138AN: 1461870Hom.: 1 Cov.: 32 AF XY: 0.0000935 AC XY: 68AN XY: 727234
GnomAD4 genome AF: 0.000361 AC: 55AN: 152294Hom.: 0 Cov.: 33 AF XY: 0.000443 AC XY: 33AN XY: 74470
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.719A>G (p.N240S) alteration is located in exon 8 (coding exon 8) of the SPPL3 gene. This alteration results from a A to G substitution at nucleotide position 719, causing the asparagine (N) at amino acid position 240 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at